HOME >> BIOLOGY >> NEWS
New Gene Alteration Find Points To Aggressive Leukemia Treatment

COLUMBUS, Ohio -- Researchers looking at a group of leukemia patients have found that a genetic defect they discovered two years ago serves as an early warning signal, calling for a speed-up in these patients’ treatment.

The defect is a duplication of a small part of the ALL1 gene. Patients who have this alteration fall out of remission three times faster than those who don’t and their survival is slightly more than half that of patients who don’t have the defect.

The scientists reported their discovery in the journal Cancer Research.

The gene defect appears in patients suffering from acute myeloid leukemia (AML), a cancer that afflicts about one in 100,000 people. The disease increases as the population ages and the prognosis of patients with the disease worsens with age. Perhaps 40 percent of those with AML can be cured using appropriate therapies. Without treatment, AML can kill in a few months.

“This is one of only a few instances where we’ve cloned a gene and then figured out what it means in terms of an individual patient’s disease. What’s more, this gene defect is a sign of a poor prognosis. Finding it allows us to better plan a patient’s treatment,” explained Michael Caligiuri, co-director of the division of hematology and oncology and associate director for clinical cancer research for Ohio State University’s Comprehensive Cancer Center. The study was led by Caligiuri and Dr. Clara Bloomfield, director of the CCC and of the division of hematology and oncology.

In approximately 55 percent of the cases of AML, the patient’s chromosomes show distinctive changes that can be linked to the disease. In the remaining 45 percent however, the patients show normal cytogenetics -- that is, there are no obvious chromosomal changes.

This particular defect appears in patients who have normal cytogenetics, Caligiuri said. That is
'"/>

Contact: Michael Caligiuri
Caligiuri-1@medctr.osu.edu
(614) 293-7521
Ohio State University
28-Jan-1998


Page: 1 2

Related biology news :

1. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
2. Genetic Alterations Linked To Cancer In Some Blood Samples
3. Fly Tumor Points Way To New Understanding Of Cancer Development
4. New Evidence Points To Role For Free Radicals In Alzheimers Disease
5. "A Thousand (And More) Points Of Light" Yield New View Into Cells
6. Crater Chain On Two Continents Points To Impact From Fragmented Comet: 214Million Year-Old Event Corresponds With Mass Extinction
7. Aggressive tumor cells leave a trail in their environment that affects the spread of cancer
8. Once A Bully, Always A Bully, Invasive Non-Native Plants Tend To Be Aggressive Wherever They Find Themselves
9. Prostate Cancers Aggressiveness May Be Predicted Early By The Ratio Of Free To Total PSA
10. Leukemia stem cells identified by Stanford researchers
11. Newly Discovered Viral Gateway Into Cells Could Play Role In Diagnosis And Treatment Of Leukemia, HIV And Other Viral Diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/11/2019)... ... June 10, 2019 , ... Improved Pharma LLC announces the ... issue of AAPS PharmSciTech. The article was published online on April 29th, 2019. The ... along with Xiaoming Sean Chen of Purdue University. , The article is the most ...
(Date:6/6/2019)... ... June 05, 2019 , ... ... opening of a new network station and service center in Mexico City, Mexico. ... in the world — with more than $1.75 billion in pharmaceutical exports since ...
(Date:6/4/2019)... ... June 04, 2019 , ... In’Tech Medical SAS ( ... Q1-19 revenues of $31M, up 12% from Q1-18. The growth is associated with ... & operational excellence initiatives worldwide. , Laurent Pruvost , President & CEO ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... 10, 2019 , ... Thought Technology Ltd is pleased to ... Biofeedback Tech Ltd as its authorised distributor for the UK and Ireland. ... treatments and clinical assessment protocols to treat stress related disorders as well as ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Personalized Stem Cells Inc. (PSC) , has announced that their GMP facility for ... and Drug Branch for manufacturing. This is an important milestone for VetStem ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... interest to our methodology, processes, and diagnostic techniques. The patent applications titled ... IP rights including our proprietary sleep scoring methodology. The approval and success ...
(Date:5/22/2019)... ... May 22, 2019 , ... Artemis (formerly Agrilyst), the leading enterprise ... funding round co-led by Astanor Ventures and Talis Capital with ... iSelect Fund . The company has raised $11.75m to date and will use ...
Breaking Biology Technology:
Cached News: